CAO, Zhu Alexander,SACI, Abdel,VANASSE, K. Gary J.,GROWNEY, Joseph Daniel
申请号：
AU2017210520
公开号：
AU2017210520A1
申请日:
2017.08.01
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017210520A120170817.pdf#####1: dar Intrwovn NRPortbl DCC DAR 15366616_l.docx-27 07/2017 ABSTRACT The present invention relates to a Pim kinase inhibitor compound that can be used alone or in a pharmaceutical combination. One such combination comprises (a) a JAK inhibitor compound, (b) a Pim kinase inhibitor compound, and optionally, at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment of a myeloid neoplasm or leukemia； a pharmaceutical composition comprising such a combination； the use of such a combination for the preparation of a medicament for the treatment of myeloid neoplasm or leukemia； a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use； and to a method of treatment of a mammal, especially a human.
